Replay available

Dr Martens Plc (DOCMF) Q2 2026 Earnings Call

Dr Martens Plc (OTC: DOCMF) Q2 2026 earnings conference call, held 2025-11-20. Replay captured from the company's public earnings webcast.

Thu, November 20, 2025 at 4:30 AMendedReplay
Dr Martens Plc (DOCMF) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

John Stephenson

Analyst at Pillhut

Kate Hout

Analyst at Investec

Anne Critchlow

Analyst at Berenberg

Replay transcript excerpt

Like I said, we've been busy, and I'm proud of what our people have been up to in the first half of the year. So let's get into it. I know you would have seen the statement this morning, and so Giles and I will cover three things. I'll share a brief introduction, just frame a bit of what we're up to, and then Giles will pull out some of the key themes from our performance in the first half, and then I'll give you an update on the strategy that we introduced to you back in June. So I'm pleased to report, as we saw on the slide, that we are on track with the execution of the strategy and on track with our guidance for the year. I'll go into each one of the four levers later on, but I also want to be clear that we still have some challenges that we're addressing, particularly with boots and sandals and with EMEA direct-to-consumer. Yet overall, we're doing what we said we would do. with good cash generation and cost control driving good financial progress. And as I will keep telling you, I'm laser-focused on execution, and the work we've done to date gives me confidence that we will deliver our four-year results as planned. Giles will go into more detail now on how we performed in that. Thank you EJ and good morning everyone. I'm here today to talk through our first half results and I'm pleased to report good progress in all our key metrics. But before I go into any detail, I felt it important to share with you how we're making decisions and how we're running the business. We are focusing on making the right decisions for the long term while making sure we control our costs and our financials in the short term, as evidenced through our Cost Action Plan last year and our significant reduction in our leverage position. This means we have FY27 and beyond at the front of ou...

More from Dr. Martens Plc